Prominent players in the Cardiac Tissue Engineering market include, Terumo corporation (Japan), Artivion, Inc. (US), Baxter ...

Understanding why newborns, but not adults, can regenerate the heart could lead to treatments that "reprogram" adult ...

Researchers at the University of Toronto's Institute of Biomedical Engineering have found that studying blood flow in leg ...

Every year, more than 5 million people in the U.S. are diagnosed with heart valve disease, but this condition has no ...

Georgia Tech researchers 3D print bioresorbable heart valves. Once implanted, the patient-specific valves will be absorbed by ...

Researchers have developed engineered heart muscle allografts from stem cells, showing promising results in repairing heart ...

After a heart attack, most adults struggle to regenerate healthy heart tissue, leading to scar-tissue buildup and, often, heart failure. A new Northwestern Medicine study in experimental animals ...

Novoheart’s CTScreen™ system has been installed at UMC Utrecht, equipping Regenerative Medicine Center with advanced high-throughput tools to accelerate human cardiac disease modeling and therapeutic ...

After a heart attack, most adults struggle to regenerate healthy heart tissue, leading to scar-tissue ... Feb. 7, 2025 — Women who have experienced pregnancy complications have an increased risk ...

The Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and NTT Research, Inc., a division of NTT, announced the publication of research showing an application of ...